Martinelli-BoneschiFEspositoFBrambillaP. A genome-wide association study in progressive multiple sclerosis. Mult Scler2012; 18: 1384–1394.
2.
BrambillaPEspositoFLindstromE. Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans. Neurosci Lett2012; 530: 155–160.
3.
SadovnickADRischNJEbersGC. Canadian collaborative project on genetic susceptibility to MS, phase 2: Rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci1998; 25: 216–221.
4.
PoserCMPatyDWScheinbergL. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol. 1983; 13: 227–231.
5.
PolmanCHReingoldSCEdanG. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
6.
TrinhJVilarino-GuellCDonaldA. STX6 rs1411478 is not associated with increased risk of Parkinson’s disease. Parkinsonism Relat Disord2013; 19: 563–565.
7.
ComiG. Disease-modifying treatments for progressive multiple sclerosis. Mult Scler2013; 19: 1428–1436.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
